![Jeanne Ohrnberger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Jeanne Ohrnberger worked as a Laboratory Director at Armune BioScience, Inc. and CLIA, Inc. She earned a doctorate degree from Wayne State University (Michigan) in 1994.
Anciens postes connus de Jeanne Ohrnberger
Sociétés | Poste | Fin |
---|---|---|
Armune BioScience, Inc.
![]() Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | Corporate Officer/Principal | 01/12/2017 |
CLIA, Inc. | Corporate Officer/Principal | - |
Formation de Jeanne Ohrnberger
Wayne State University (Michigan) | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Armune BioScience, Inc.
![]() Armune BioScience, Inc. Medical/Nursing ServicesHealth Services Armune BioScience, Inc. researches and develops diagnostic and prognostic tests for prostate, lung, and breast cancers that may allow physicians and patients to make more personalized treatment decisions for a better prognosis. The firm's technology is based on evidence that the immune system’s early warning signals provide critical biological insight to improve cancer detection and enhance therapeutic effectiveness. The company was founded by Eli L. Thomssen in 2008 and is headquartered in Kalamazoo, MI. | Health Services |
CLIA, Inc. |